Metraipolis › archive › dc_9ca42b707482

The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study — Europe PMC PMID:35085228

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35085228
DOI
10.1371/journal.pmed.1003859
License (as archived)
CC0-1.0
Archived
2026-10-31T11:56:17.197Z
SHA-256 of the archived text
026100fb53ea2355f518ef19909e991584e704d5f5ccf957683fab8e3bff21aa
Stable URL of this page
https://metraipolis.com/documento/dc_9ca42b707482

How to cite

The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study — Europe PMC PMID:35085228 — Europe PMC (en), https://europepmc.org/article/MED/35085228 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_9ca42b707482 (Metraipolis archive dc_9ca42b707482, sha256 026100fb53ea2355f518ef19909e991584e704d5f5ccf957683fab8e3bff21aa)
BibTeX
@misc{dc9ca42b707482,
  title = {The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study — Europe PMC PMID:35085228},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35085228},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_9ca42b707482; sha256 026100fb53ea2355f518ef19909e991584e704d5f5ccf957683fab8e3bff21aa},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35085228. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Numerous epidemiological studies have investigated the role of blood lipids in prostate cancer (PCa) risk, though findings remain inconclusive to date. The ongoing research has mainly involved observational studies, which are often prone to confounding. This study aimed to identify the relationship between genetically predicted blood lipid concentrations and PCa. Methods and findings: Data for low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides (TG), apolipoprotein A (apoA) and B (apoB), lipoprotein A (Lp(a)), and PCa were acquired from genome-wide association studies in UK Biobank and the PRACTICAL consortium, respectively. We used a two-sample summary-level Mendelian randomisation (MR) approach with both univariable and multivariable (MVMR) models and utilised a variety of robust methods and sensitivity analyses to assess the possibility of MR assumptions violation. No association was observed between genetically predicted concentrations of HDL, TG, apoA and apoB, and PCa risk. Genetically predicted LDL concentration was positively associated with total PCa in the univariable analysis, but adjustment for HDL, TG, and Lp(a) led to a null association. Genetically predicted concentration of Lp(a) was associated with higher total PCa risk in the univariable (ORweighted median per standard deviation (SD) = 1.091; 95% CI 1.028 to 1.157; P = 0.004) and MVMR analyses after adjustment for the other lipid traits (ORIVW per SD = 1.068; 95% CI 1.005 to 1.134; P = 0.034). Genetically predicted Lp(a) was also associated with advanced (MVMR ORIVW per SD = 1.078; 95% CI 0.999 to 1.163; P = 0.055) and early age onset PCa (MVMR ORIVW per SD = 1.150; 95% CI 1.015,1.303; P = 0.028). Although multiple estimation methods were utilised to minimise the effect of pleiotropy, the presence of any unmeasured pleiotropy cannot be excluded and may limit our findings. Conclusions: We observed that genetically predicted Lp(a) concentrations were associated with an increased PCa risk. Future studies are required to understand the underlying biological pathways of this finding, as it may inform PCa prevention through Lp(a)-lowering strategies.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS medicine, 2022 (prima pubblicazione 2022-01-27).
Identificativi: PMID 35085228 · PMCID PMC8794090 · DOI 10.1371/journal.pmed.1003859.
Descrittori MeSH principali: Genome-Wide Association Study.
Pagina: https://europepmc.org/article/MED/35085228 — https://doi.org/10.1371/journal.pmed.1003859. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-31T11:45:32.163Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.